BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10806565)

  • 21. Correct timing of administration of diuretic agents for the treatment of ovarian hyperstimulation syndrome.
    Bar-Hava I; Homburg R
    Gynecol Endocrinol; 1993 Mar; 7(1):63-5. PubMed ID: 8506765
    [No Abstract]   [Full Text] [Related]  

  • 22. [The hyperstimulation syndrome].
    Kleinstein J
    Gynakologe; 1991 Jun; 24(3):130-5. PubMed ID: 1909990
    [No Abstract]   [Full Text] [Related]  

  • 23. [Ovarian hyperstimulation syndrome in medically assisted reproduction].
    Rogé P; Erny R
    Rev Fr Gynecol Obstet; 1994 Oct; 89(10):495-501. PubMed ID: 7817078
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Leukocyte behaviour and permeability in the rat mesenteric microcirculation following induction of ovulation.
    Katayama T; Kusanagi Y; Kiyomura M; Ochi H; Ito M
    Hum Reprod; 2003 Jun; 18(6):1179-84. PubMed ID: 12773443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is continuation of a gonadotrophin-releasing hormone agonist (GnRHa) necessary for women at risk of developing the ovarian hyperstimulation syndrome?
    Wada I; Matson PL; Horne G; Buck P; Lieberman BA
    Hum Reprod; 1992 Sep; 7(8):1090-3. PubMed ID: 1400932
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ovarian hyperstimulation syndrome and thrombotic events.
    Mor YS; Schenker JG
    Am J Reprod Immunol; 2014 Dec; 72(6):541-8. PubMed ID: 25146913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Luteal phase hyperprolactinemia during ovulation induction with human menopausal gonadotropins: incidence, recurrence, and effect on pregnancy rates.
    Tippet PD; Simon JA; Rifka SM; Falk RJ
    Obstet Gynecol; 1989 Apr; 73(4):613-6. PubMed ID: 2494621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elevated interleukin-10 and sex steroid levels in peritoneal fluid of patients with ovarian hyperstimulation syndrome.
    Manolopoulos K; Lang U; Gips H; Braems GA
    Eur J Obstet Gynecol Reprod Biol; 2001 Dec; 99(2):226-31. PubMed ID: 11788177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ovarian hyperstimulation syndrome due to exogenous gonadotropin administration.
    Bider D; Menashe Y; Oelsner G; Serr DM; Mashiach S; Ben-Rafael Z
    Acta Obstet Gynecol Scand; 1989; 68(6):511-4. PubMed ID: 2520805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute cerebrovascular accidents with severe ovarian hyperstimulation syndrome.
    El Sadek MM; Amer MK; Fahmy M
    Hum Reprod; 1998 Jul; 13(7):1793-5. PubMed ID: 9740425
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Severe early ovarian hyperstimulation syndrome following GnRH agonist trigger with the addition of 1500 IU hCG.
    Seyhan A; Ata B; Polat M; Son WY; Yarali H; Dahan MH
    Hum Reprod; 2013 Sep; 28(9):2522-8. PubMed ID: 23633553
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment and prevention of the ovarian hyperstimulation syndrome].
    Morán C; Ortega E; Fiorelli S; Murillo A; Zárate A
    Ginecol Obstet Mex; 1992 Jan; 60():4-7. PubMed ID: 1555790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized controlled trial comparing the efficacy and safety of two HMG preparations gaining their LH bioactivity from different HCG sources.
    Lockwood G; Cometti B; Bogstad J; Erb K; De Geyter C; Urbancsek J; Trevisan S; Pocate-Cheriet K; de Ziegler D
    Reprod Biomed Online; 2017 Jul; 35(1):17-27. PubMed ID: 28476487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Native gonadotropin-releasing hormone for triggering follicular maturation in polycystic ovary syndrome patients undergoing human menopausal gonadotropin ovulation induction.
    Blumenfeld Z; Lang N; Amit A; Kahana L; Yoffe N
    Fertil Steril; 1994 Sep; 62(3):456-60. PubMed ID: 8062938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ovarian hyperstimulation syndrome manifests as acute unilateral hydrothorax.
    Daniel Y; Yaron Y; Oren M; Peyser MR; Lessing JB
    Hum Reprod; 1995 Jul; 10(7):1684-5. PubMed ID: 8582961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adnexal torsion as a complication of superovulation for ovum retrieval.
    Chin NW; Friedman CI; Awadalla SG; Miller FA; Kim MH
    Fertil Steril; 1987 Jul; 48(1):149-51. PubMed ID: 3109961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is multiple pregnancy an unavoidable complication of ovulation induction? The case for pulsatile GnRH.
    Filicori M; Cognigni GE; Arnone R; Carbone F; Falbo A; Tabarelli C; Pari C; Ciampaglia W; Casadio P; Spettoli D; Pecorari R
    Eur J Obstet Gynecol Reprod Biol; 1996 Apr; 65 Suppl():S19-21. PubMed ID: 8735007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ultrasonographic and clinical correlates of menotropin versus sequential clomiphene citrate: menotropin therapy for induction of ovulation.
    Tal J; Paz B; Samberg I; Lazarov N; Sharf M
    Fertil Steril; 1985 Sep; 44(3):342-9. PubMed ID: 3928406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monitoring of ovulation induction with HMG-HCG therapy by plasma estrogen and progesterone.
    Muechler EK; Kohler D; Huang KE
    Int J Fertil; 1981; 26(4):273-8. PubMed ID: 6120908
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Ovarian hyperstimulation in medically assisted reproduction: which practical approach?].
    Priou G
    Contracept Fertil Sex; 1996 Sep; 24(9):647-9. PubMed ID: 8998510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.